Bradley Grobler, Vice President of Sales, Pharma & Biopharma Europe, describes how Actylis meets global demands for (bio)pharmaceutical development and manufacturing programs during CPhI 2023.
Actylis
Advertisement
Articles by Actylis
Advertisement
Latest Updated Articles
Importance of a Hybrid Approach to Manufacturing and SourcingPublished: January 9th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Integrating Sustainability into the Core of Pharmaceutical Science
5
